We use cookies to ensure that the website works as intended and to collect statistics on its use so that we can improve your web site experience.

×
analyst information

Consensus

Overview of consensus estimates per 2 November 2021.
Participants:  SEB, Pareto Securities and DNB

 

thumbnail_image002

 

 

Investor Contact

CARL CHR. BACHKE

SVP Investor Relations, Aker BioMarine ASA

+47 909 808 48

carl.bachke@akerbiomarine.com

 

 

ANNUAL REPORT 2020

IMPROVING HUMAN AND PLANETARY HEALTH

Aker BioMarine is a biotech innovator and Antarctic krill-harvesting company, dedicated to improving human and planetary health. Aker BioMarine’s fully transparent value chain stretches from sustainable krill harvesting in pristine Antarctic waters through its Montevideo logistics hub, Houston production plant, and to customers around the world.